Showing posts with label Ventilator Market. Show all posts
Showing posts with label Ventilator Market. Show all posts

Wednesday, October 7, 2020

Ventilator Market to Progress at a Healthy CAGR in Coming Years

 Rising prevalence of respiratory diseases, increasing incidence of preterm births, urbanization and growing pollution levels, high prevalence of tobacco smoking, rapid growth in the geriatric population, and rising number of ICU beds are the major factors driving the growth of the ventilators market.

The report Ventilator Market is projected to reach USD 1.72 billion by 2027 from USD 0.93 billion in 2019, at a CAGR of 8.0%.

Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=11018337

 On the basis of interface, the invasive ventilation segment accounted for the largest share of the ventilators market. The large share of this segment is due to the high prevalence of tobacco smoking, increasing prevalence of chronic diseases such as COPD & asthma, rapid growth in the geriatric population, and improving healthcare affordability in developed countries.

On the basis of mobility, the intensive case ventilators segment accounted for the largest share of the global ventilators market. The large share of this segment is attributed to the rising number of ICU beds and rising adoption of equipping the ICU beds with ventilators.

Based on type, the adult/pediatric ventilators segment held the largest market share of ventilators market. The large share of this segment can be attributed to the large patient population with severe COPD, asthma, and other chronic respiratory diseases; rising number of smokers; and rapid growth in the geriatric population.

Based on end user, the hospitals & clinics segment accounted for the largest share of the ventilators market.

North America accounted for the largest share of the ventilators market in 2018, followed by Europe and Asia Pacific. 

Speak To Analyst: -https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=11018337  

The prominent players in the global ventilators market are Philips Healthcare (Netherlands), ResMed (US), Medtronic (Ireland), Becton, Dickinson and Company (US), Getinge (Sweden), Dräger (Germany), Smiths Group (UK), Hamilton Medical (Switzerland), GE Healthcare (US), Fisher & Paykel (New Zealand), Air Liquide (France), Zoll Medical (US), Allied Healthcare Products (US), Airon (US), Mindray (China), and Schiller (Switzerland).

Wednesday, August 21, 2019

Hospitals & Clinics are the Largest End Users of Ventilators


Factors such as increasing number of preterm births, rapid growth in the geriatric population, rising prevalence of respiratory diseases, and rising number of ICU beds are expected to drive the growth of the ventilators market during the forecast period. In addition, the growing demand for home care therapeutics and higher growth in developing countries like China, India, and Brazil are driving the demand for ventilators.

The report "Ventilator Market is projected to reach USD 1.72 billion by 2027 from USD 0.93 billion in 2019, at a CAGR of 8.0%.

Market Drivers: -
                    1 Rising Prevalence of Respiratory Diseases
                              1.1 Urbanization and Growing Pollution Levels
                              1.2 High Prevalence of Tobacco Smoking
                              1.3 Changing Lifestyles
                   2 Rapid Growth in the Geriatric Population
                   3 Increasing Number of Preterm Births
                   4 Rising Number of ICU Beds

Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=11018337

The report analyzes the global ventilator market by mobility, mode, interface, type, end user, and region.

On the basis of mobility, the intensive case ventilators segment accounted for the largest share of the global ventilators market. The large share of this segment is attributed to the rising number of ICU beds and rising adoption of equipping the ICU beds with ventilators.
On the basis of interface, the invasive ventilation segment accounted for the largest share of the ventilators market. The large share of this segment is due to the high prevalence of tobacco smoking, increasing prevalence of chronic diseases such as COPD & asthma, rapid growth in the geriatric population, and improving healthcare affordability in developed countries.
Based on end user, the hospitals & clinics segment accounted for the largest share of the ventilators market. The large share of this segment can be attributed to the increasing number of private and public hospitals, economic expansion and focus of government on broader healthcare policies, and increasing per capita income.
Based on type, the adult/pediatric ventilators segment held the largest market share of ventilators market.

Read More: -  https://www.marketsandmarkets.com/PressReleases/ventilators.asp

Regional Analysis:-

North America accounted for the largest share of the ventilators market in 2018, followed by Europe and Asia Pacific. The presence of major market players, the rising geriatric population, and high prevalence of smoking, high prevalence of respiratory diseases, highly developed healthcare system, and high healthcare expenditure are the other factors responsible for the large share of North America in the ventilators market.

Key Players:-

The prominent players in the global ventilators market are Philips Healthcare (Netherlands), ResMed (US), Medtronic (Ireland), Becton, Dickinson and Company (US), Getinge (Sweden), Dräger (Germany), Smiths Group (UK), Hamilton Medical (Switzerland), GE Healthcare (US), Fisher & Paykel (New Zealand), Air Liquide (France), Zoll Medical (US), Allied Healthcare Products (US), Airon (US), Mindray (China), and Schiller (Switzerland).

Thursday, July 4, 2019

Ventilators Market worth $1.72 billion by 2027


The report "Ventilator Market by Mobility (Intensive Care, Portable), Type (Adult, Infant), Mode (Volume, Pressure, Combined), Interface (Invasive, Non-invasive), End User (Hospital, Home Care, Ambulatory Care Center, EMS) - Global Forecast to 2027", is projected to reach USD 1.72 billion by 2027 from USD 0.93 billion in 2019, at a CAGR of 8.0%. Rising prevalence of respiratory diseases, increasing incidence of preterm births, urbanization and growing pollution levels, high prevalence of tobacco smoking, rapid growth in the geriatric population, and rising number of ICU beds are the major factors driving the growth of the ventilators market.

Browse 185 market data Tables and 56 Figures spread through 212 Pages and in-depth TOC on "Ventilator Market ".


“By mobility, the intensive care ventilators segment accounted for the largest share of the ventilators market in 2018.”

On the basis of mobility, the intensive case ventilators segment accounted for the largest share of the global ventilators market. The large share of this segment is attributed to the rising number of ICU beds and rising adoption of equipping the ICU beds with ventilators.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=11018337 

“By interface, the invasive ventilation segment accounted for the largest share of the ventilators market in 2018.”

On the basis of interface, the invasive ventilation segment accounted for the largest share of the ventilators market. The large share of this segment is due to the high prevalence of tobacco smoking, increasing prevalence of chronic diseases such as COPD & asthma, rapid growth in the geriatric population, and improving healthcare affordability in developed countries.

“By end user, the hospitals and clinics segment of end user accounted for the largest share of ventilators market in 2018.”

Based on end user, the hospitals & clinics segment accounted for the largest share of the ventilators market. The large share of this segment can be attributed to the increasing number of private and public hospitals, economic expansion and focus of government on broader healthcare policies, and increasing per capita income.

“By type, the adult/pediatric ventilators segment held the largest market share of ventilators market in 2018.”

Based on type, the adult/pediatric ventilators segment held the largest market share of ventilators market. The large share of this segment can be attributed to the large patient population with severe COPD, asthma, and other chronic respiratory diseases; rising number of smokers; and rapid growth in the geriatric population.

Read more: - https://www.marketsandmarkets.com/PressReleases/ventilators.asp

“North America dominated the market in 2018.”

North America accounted for the largest share of the ventilators market in 2018, followed by Europe and Asia Pacific. The presence of major market players, the rising geriatric population, high prevalence of smoking, high prevalence of respiratory diseases, highly developed healthcare system, and high healthcare expenditure are the other factors responsible for the large share of North America in the ventilators market.

The prominent players in the global ventilators market are Philips Healthcare (Netherlands), ResMed (US), Medtronic (Ireland), Becton, Dickinson and Company (US), Getinge (Sweden), Dräger (Germany), Smiths Group (UK), Hamilton Medical (Switzerland), GE Healthcare (US), Fisher & Paykel (New Zealand), Air Liquide (France), Zoll Medical (US), Allied Healthcare Products (US), Airon (US), Mindray (China), and Schiller (Switzerland).

Wednesday, June 19, 2019

Adult/Pediatric Ventilators Segment Will Continue to Dominate the Ventilators Market


The report "Ventilator Market by Mobility (Intensive Care, Portable), Type (Adult, Infant), Mode (Volume, Pressure, Combined), Interface (Invasive, Non-invasive), End User (Hospital, Home Care, Ambulatory Care Center, EMS) - Global Forecast to 2023", The global ventilators market is projected to reach USD 1,261.9 Million by 2023 from USD 859.9 Million in 2018, at a CAGR of 8.0%. Rising prevalence of respiratory diseases, increasing incidence of preterm births, urbanization and growing pollution levels, high prevalence of tobacco smoking, rapid growth in the geriatric population, and rising number of ICU beds are the major factors driving the growth of the ventilators market. 

Further more information in details about Ventilator Market Best Chance to increase growth in revenue of your company.
 


North America accounted for the largest share of the ventilators market in 2017, followed by Europe and Asia Pacific. The presence of major market players, the rising geriatric population, high prevalence of smoking, high prevalence of respiratory diseases, highly developed healthcare system, and high healthcare expenditure are the other factors responsible for the large share of North America in the ventilators market.
 


Thursday, February 7, 2019

Philips Healthcare (Netherlands), ResMed (US), Medtronic (Ireland), Becton, Dickinson and Company (US), Getinge Group (Sweden), and Drager (Germany) Dominated the Ventilators Market


The global Ventilators Market is projected to reach USD 1,261.9 million by 2023 from USD 859.9 million in 2018, at a CAGR of 8.0%. Rising prevalence of respiratory diseases, increasing incidence of preterm births, urbanization and growing pollution levels, high prevalence of tobacco smoking, rapid growth in the geriatric population, and rising number of ICU beds are the major factors driving the growth of the ventilators market.

The global ventilators market is consolidated at the top with the presence few big players in the market. However, on regional basis there are many local, regional, and global players. Philips Healthcare (Netherlands), ResMed (US), Medtronic (Ireland), Becton, Dickinson and Company (US), Getinge Group (Sweden), Drager (Germany), Hamilton Medical (Switzerland), and Smiths Medical (UK) were the major players in this market. The companies are mainly focusing on product launches and acquisitions.


View more detailed TOC @
 


Philips Healthcare (Netherlands) held the leading position in global ventilators market in 2017. The company has a diversified product portfolio, which includes a wide range of ventilators, such as Respironics V680, Respironics BiPAP Focus, Respironics V680 non-invasive ventilators, and Respironics Trilogy. The company’s leading position can be attributed to its strong distribution network across the globe, which enables it to serve customers in the Americas, Europe, Africa, and Asia Pacific. The company’s strategic focus on introducing innovative products is indicative of the significant R&D investments made. This is evident from the launch of its Respironics V680 in Canada in 2015 and some European market in 2016.

ResMed (US) has established a strong brand in the global ventilators market. The company’s key growth strategies such as product launches, mergers & acquisitions, and expansions have helped it to maintain its position in this competitive market. Geographically, the company has a strong distribution channel across the globe with facilities in about 150 countries across North America, South America, Europe, Asia, and the Middle East & Africa. The company offers products for the diagnosis, treatment, and management of respiratory disorders, such as sleep apnea, chronic obstructive pulmonary disease (COPD), and other chronic diseases. ResMed focuses on developing new and innovative products. In June 2016, the company launched the iVAPS (intelligent Volume-Assured Pressure Support) therapy mode for Astral life support ventilators.


 

Medtronic (Ireland) held the third position in the ventilators market in 2017. The company acquired Covidien plc in January 2015 that helped it to offer a varied range of ventilators. Medtronic offers a comprehensive portfolio of acute care ventilators and portable ventilators. The company’s key growth strategies, such as the expansion of existing production facilities and strengthening of R&D capabilities have helped it to maintain its position in this competitive market. Geographically, the company has a strong presence in North America. The revenue generated from the company’s minimally invasive segment is expected to grow in the near future owing to the successful implementation of organic and inorganic growth strategies.

Antibody Therapeutics Market : Driven by Advances in Biologics and Expanding Clinical Applications

The global antibody therapeutics market is projected to grow from USD 311.2 billion in 2026 to USD 597.1 billion by 2035, at a CAGR of 7.5...